Close Icon

Business Development Team Solutions

Drive growth and ensure customer satisfaction.

Key Takeaway

Nurturing relationships with existing customers and bringing new customers on board is easier for business development professionals who rely on Saama for actionable insights. Our data aggregation and AI-powered analytics tools show sponsors that you take their needs more seriously than your competition does.

 

  • Utilize role-based dashboards and analytics that show real-time performance data
  • Use historical data patterns to predict what will happen next in your current trials
  • Take a risk-based approach to monitoring that aligns with ICH E6(R2) guidelines
  • Present a value proposition that instills confidence in current and prospective partners
 

Operations Insights

With Operations Insights in place, your CRO’s business development leaders can ensure existing customers that their studies are on-track toward successful completion. They can also attract new business by explaining the power of data visibility to drive performance and reduce risk.

  • Win sponsors who want to avoid issues over data quality or data management
  • Improve communication and collaboration from planning to completion
  • Gain insights for more accurate account planning, management, and execution
Learn More
 

Risk Based Monitoring

Sponsors are becoming increasingly interested in complying with ICH E6(R2) guidelines, and Saama delivers a powerful solution that goes far beyond traditional site operations.

  • Reduce risk through early notification of issues at specific sites
  • Allocate site visitation resources more effectively
  • Use custom KRIs and root-cause analysis to identify and address issues more quickly
Learn More
 

Clinical Insights

Business development professionals can offer greater peace of mind to sponsors with Clinical Insights, a proven way to monitor studies and ensure proper documentation. With safety and subject-level data all in one place, critical medical review processes can be managed much more effectively and efficiently.

  • Set alerts to identify issues sooner for faster action
  • View data changes in real-time, using dynamic line listings and graphical patient profiles
  • Use detailed labs, with access to actual test results, to visualize trends and identify outliers
Learn More

Access Out-of-the-Box Features in 4 Weeks—Guaranteed.

Saama can put you on the fast track to clinical trial process innovation.

Terms & Conditions

By inquiring about Saama’s Database Lock in a Day, you agree to be contacted by Saama and to allow Saama to use, maintain, store, and protect your personal data in accordance with our Privacy Policy.

Eligibility details are for informational purposes only. Saama, in its sole discretion, will determine your eligibility based on the information you disclose as part of the intake process. If Saama determines that you are eligible to participate, you will be notified by separate email. Eligibility depends on certain criteria, such as the size of your company, the types of clinical trials you sponsor, and the number of patients in–and stages of–your current clinical trials.

By completing the request form, you represent that you have authority to proceed on behalf of your company. Should you agree to participate, you agree to reasonably cooperate with Saama in following the guidelines and procedures required for integrating, standardizing, and analyzing your data. Participation requires the use of our Smart Data Quality application, a technology-agnostic AI engine that sits on top of your current infrastructure. The application can be used immediately, and you’re only charged for the services you use based on a predetermined estimate.

Information you share with Saama during your participation may be anonymized and/or aggregated, and made available publicly in Saama marketing materials. This information may include: types of systems and processes involved, types of departments involved, and size and regional location of your company. Such information will never be directly associated with you, nor will you or your company be identifiable without express written permission.